Abstract:BACKGROUND: Neuropeptide Y (NPY) may influence differentiation of Th cells. It is assumed that the immunological pathology of experimental allergic encephalomyelitis (EAE) is related to abnormal differentiation of Th cellsOBJECTIVE: To investigate the effect of NPY on white matter demyelination, the serum levels interleukin-4 (IL-4) and gamma-interferon (IFN-gamma), as well as EAE pathogenesis in an EAE guinea pig model following NPY injection into the lateral cerebral ventricle.DESIGN, TIME AND SETTING: A randomized controlled animal study, which was performed in the Infection Immunity Animal Laboratory, Affiliated Hospital of Luzhou Medical College, China, from October 2005 to April 2006.MATERIALS: Thirty healthy female guinea pigs of 8-12 weeks of age, and 10 healthy female rats of three months of age were used. NPY was provided by Sigma Company, USA. NPY kit was provided by Beijing Huaying Biotechnology Institute, China.METHODS: Thirty guinea pigs were randomly divided into three groups: normal control group, EAE model group, and NPY intervention group (n = 10 per group). Normal control group and EAE model group: Saline (10 mu L, once) was injected into the lateral cerebral ventricle. After one week, the same volume of Freund's adjuvant complete was either injected subcutaneously into two post-palms or EAE was modeled. NPY intervention group: EAE was modeled after one week and NPY was injected (10 p L of 6 nmol NPY, once) into the lateral cerebral ventricle. Myelin basic protein (MBP) antigen made from rat spinal cord homogenate and Freund's adjuvant complete were injected subcutaneously into both post-palms (0.2 mL per palm) to establish the EAE model.MAIN OUTCOME MEASURES: White matter demyelination of the cerebrum, cerebellum, brain stem, and spinal cord were observed by light microscopy after HE staining. Levels of serum IFN-gamma and IL-4 were detected by the double antibody sandwich ABC-ELISA technique. NPY content was detected by radioimmunoassay.RESULTS: Pathological alterations in the NPY intervention groups were reduced compared to those in the EAE model group, suggesting a reduction and remission of white matter demyelination with NPY treatment. When compared to the model group, the serum IL-4 level was increased in the NPY intervention group during the high-frequent EAE stage (P < 0.01), but the serum IFN-gamma level was decreased (P < 0.01). Furthermore, the EAE latency was prolonged (1) < 0.01), the neurological scores were decreased in the high-frequent EAE stage (P < 0.01), and the death rate was decreased (P < 0.05). NPY content and the serum IL-4 level at the peak stage were positively correlated with those in the latent phase (r = 0.863-0.900, P < 0.01). but negatively correlated with neurological scores at the peak stage (r = -0.068 to -0.863, P < 0.05-0.01). The IFN-gamma level at the peak stage was negatively correlated to that in the latent phase (r = -0.683-0.650, P < 0.05), but positively correlated to neurological scores at the peak stage (r = 0.975, 0.845, P < 0.05).CONCLUSION: NPY injection into the lateral cerebral ventricle can promote the secretion of IL-4, inhibit the production of IFN-gamma, relieve white matter demyelination, and inhibit EAE attack in an experimental model of EAE.

Effect of Neuropeptide Y on White Matter Demyelination and Serum Interleukin-4 and Gamma-Interferon Levels in the Guinea Pig with Experimental Allergic Encephalomyelitis

Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model.

C16 Peptide Shown to Prevent Leukocyte Infiltration and Alleviate Detrimental Inflammation in Acute Allergic Encephalomyelitis Model

Dose-dependent anti-inflammatory and neuroprotective effects of an α β 3 integrin-binding peptide

The Morphological Changes of the Model with EAE Pre-inj eced the Gap Junction Blocker into the Lateral Cerebroventricle

Analysis of the Cellular Mechanism Underlying Inhibition of EAE after Treatment with Anti-Nkg2a F(ab′)2

Lactobacillus Rhamnosus Ameliorates Experimental Autoimmune Neuritis Via Modulation of Gut Microbiota and Metabolites.

Increase in anti-astrocyte antibodies in the serum of guinea pigs during active stages of experimental autoimmune encephalomyelitis

Therapeutic Effect of Progesterone for Rats with Experimental Allergic Encephalomyelitis

Functions of T-cell Subsets and Their Related Cytokines in the Pathological Processes of Autoimmune Encephalomyelitic Mice.

The Influence on Immunological Status of Experimental Allergic Neuritis by Intervention of Tripterygium Polyglucoside

Effects of the synergetical potentiation of interleukin-12 and interleukin-18 in neurosis induced by T cell lines specific for myelin-specific P0 protein peptides (P0180-199)

Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats.

The roles of T-lymphocyte subsets and adhesion molecules in experimental allergic neuritis

Effect on neural stem cell proliferation in experimental autoimmune encephalomyelitis

IFN-γ Deficiency Exacerbates Experimental Autoimmune Neuritis in Mice Despite a Mitigated Systemic Th1 Immune Response

The Ultrastructural Changes of the Neurons and Glia in the Brain of Experimental Autoimmune Encephalomyelitis

Effects of Central and Peripheral Administration of Neuropeptide S on the Level of Serum Proinflammatory Cytokines in Pigs

Cytokine Dichotomy in Peripheral Nervous System Influences the Outcome of Experimental Allergic Neuritis: Dynamics of Mrna Expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and Cytolysin

Combined Nasal Administration of Encephalitogenic Myelin Basic Protein Peptide 68–86 and IL-10 Suppressed Incipient Experimental Allergic Encephalomyelitis in Lewis Rats

Dynamics of Production of MIP-1α, MCP-1 and MIP-2 and Potential Role of Neutralization of These Chemokines in the Regulation of Immune Responses During Experimental Autoimmune Neuritis in Lewis Rats